单细胞多组学在淋巴瘤研究中的进展 (综述)
Chanjuan Jin1, Di Zhou2, Jun Li2
1Department of Hematology and Oncology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Oncology reports
|August 24, 2023
概括
单细胞多组学揭示了淋巴瘤的异质性和演变,为个性化治疗策略提供了精确的瘤概况. 这种方法提高了对疾病进展的理解,并有助于发现新的治疗点.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 淋巴瘤的进化是复杂的,由遗传突变和染色体转位驱动,导致瘤异质.
- 大量细胞分析限制了对复杂淋巴瘤进展和个体瘤特征的理解.
研究的目的:
- 系统地审查淋巴瘤单细胞多组体分析的进展.
- 探索这些技术的应用,以了解淋巴瘤的演变,耐药性和治疗策略.
主要方法:
- 单细胞基因组学,转录基因组学和表观基因组学试验.
- 对淋巴瘤样本的分析以描述瘤组件和微环境.
- 关于淋巴瘤研究中单细胞多组的当前文献的综述.
主要成果:
- 单细胞多组学提供了对淋巴瘤异质性,突变时间和疾病进展的详细见解.
- 这些方法能够精确地描述个体瘤生物学,超越了批量分析的局限性.
- 进步包括单细胞测序,微环境分析和生物标志物开发.
结论:
- 单细胞多组学显著提高了对淋巴瘤起源和演变的理解.
- 这种方法有助于识别新的淋巴瘤生物标志物和个性化治疗策略.
- 未来的前景包括针对免疫检查点和有效治疗的分子机制.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...